Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Capital Reinvestment Ratio
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥110.78 Million) in capital expenditures (CN¥21.06 Million). Check 600329 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Capital Reinvestment Ratio (2001–2024)
This chart tracks Tianjin Zhongxin Pharmaceutical Group Corp Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see Tianjin Zhongxin Pharmaceutical Group Co cash conversion from operations.
Annual Capital Reinvestment Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year Capital Reinvestment Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. See 600329 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | CN¥924.67 Million | CN¥117.81 Million | ▼ -37.8% |
| 2023 | 0.20x | CN¥688.49 Million | CN¥140.93 Million | ▲ +28.5% |
| 2022 | 0.16x | CN¥677.25 Million | CN¥107.90 Million | ▼ -13.5% |
| 2021 | 0.18x | CN¥852.40 Million | CN¥156.95 Million | ▼ -34.6% |
| 2020 | 0.28x | CN¥671.42 Million | CN¥189.16 Million | ▼ -32.1% |
| 2019 | 0.41x | CN¥495.49 Million | CN¥205.61 Million | ▼ -17.4% |
| 2018 | 0.50x | CN¥350.14 Million | CN¥175.81 Million | ▲ +81.4% |
| 2016 | 0.28x | CN¥419.90 Million | CN¥116.20 Million | ▲ +7.7% |
| 2015 | 0.26x | CN¥360.58 Million | CN¥92.64 Million | ▲ +5.1% |
| 2014 | 0.24x | CN¥286.85 Million | CN¥70.15 Million | ▼ -27.9% |
| 2013 | 0.34x | CN¥213.44 Million | CN¥72.42 Million | ▼ -82.9% |
| 2012 | 1.98x | CN¥20.81 Million | CN¥41.18 Million | ▲ +699.8% |
| 2011 | 0.25x | CN¥173.88 Million | CN¥43.02 Million | ▼ -50.0% |
| 2010 | 0.49x | CN¥139.04 Million | CN¥68.79 Million | ▼ -52.4% |
| 2009 | 1.04x | CN¥83.41 Million | CN¥86.74 Million | ▲ +322.2% |
| 2008 | 0.25x | CN¥155.77 Million | CN¥38.36 Million | ▼ -90.8% |
| 2007 | 2.67x | CN¥20.13 Million | CN¥53.74 Million | ▲ +366.7% |
| 2005 | 0.57x | CN¥261.91 Million | CN¥149.80 Million | ▼ -97.6% |
| 2004 | 24.04x | CN¥10.50 Million | CN¥252.31 Million | ▲ +212.4% |
| 2003 | 7.70x | CN¥76.57 Million | CN¥589.20 Million | ▲ +700.3% |
| 2002 | 0.96x | CN¥187.60 Million | CN¥180.40 Million | ▲ +13.2% |
| 2001 | 0.85x | CN¥157.73 Million | CN¥133.95 Million | — |